PACS Group (PACS) Competitors $11.64 +0.03 (+0.26%) Closing price 08/29/2025 03:59 PM EasternExtended Trading$11.77 +0.13 (+1.08%) As of 08/29/2025 05:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PACS vs. RDNT, SHC, OPCH, BTSG, NAKA, WGS, CON, SGRY, PRVA, and VCYTShould you be buying PACS Group stock or one of its competitors? The main competitors of PACS Group include RadNet (RDNT), Sotera Health (SHC), Option Care Health (OPCH), BrightSpring Health Services (BTSG), KindlyMD (NAKA), GeneDx (WGS), Concentra Group Holdings Parent (CON), Surgery Partners (SGRY), Privia Health Group (PRVA), and Veracyte (VCYT). These companies are all part of the "healthcare" industry. PACS Group vs. Its Competitors RadNet Sotera Health Option Care Health BrightSpring Health Services KindlyMD GeneDx Concentra Group Holdings Parent Surgery Partners Privia Health Group Veracyte PACS Group (NYSE:PACS) and RadNet (NASDAQ:RDNT) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, profitability, media sentiment, valuation, analyst recommendations, dividends and institutional ownership. Which has stronger earnings and valuation, PACS or RDNT? PACS Group has higher revenue and earnings than RadNet. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPACS Group$3.11B0.57$112.87MN/AN/ARadNet$1.83B3.02$2.79M-$0.20-358.80 Is PACS or RDNT more profitable? PACS Group has a net margin of 0.00% compared to RadNet's net margin of -0.78%. RadNet's return on equity of 2.41% beat PACS Group's return on equity.Company Net Margins Return on Equity Return on Assets PACS GroupN/A N/A N/A RadNet -0.78%2.41%0.82% Which has more risk & volatility, PACS or RDNT? PACS Group has a beta of 0.89, meaning that its stock price is 11% less volatile than the S&P 500. Comparatively, RadNet has a beta of 1.54, meaning that its stock price is 54% more volatile than the S&P 500. Do analysts prefer PACS or RDNT? PACS Group presently has a consensus target price of $33.33, indicating a potential upside of 186.37%. RadNet has a consensus target price of $71.60, indicating a potential downside of 0.22%. Given PACS Group's higher probable upside, research analysts plainly believe PACS Group is more favorable than RadNet.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PACS Group 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83RadNet 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 3 Strong Buy rating(s) 3.25 Do institutionals & insiders have more ownership in PACS or RDNT? 77.9% of RadNet shares are owned by institutional investors. 5.6% of RadNet shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the media favor PACS or RDNT? In the previous week, RadNet had 8 more articles in the media than PACS Group. MarketBeat recorded 16 mentions for RadNet and 8 mentions for PACS Group. RadNet's average media sentiment score of 1.33 beat PACS Group's score of 0.93 indicating that RadNet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PACS Group 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive RadNet 13 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryRadNet beats PACS Group on 10 of the 15 factors compared between the two stocks. Get PACS Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PACS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PACS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PACS vs. The Competition Export to ExcelMetricPACS GroupMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$1.77B$7.75B$5.71B$21.35BDividend YieldN/A2.66%6.66%3.49%P/E RatioN/A80.2683.1029.26Price / Sales0.5743.94544.9152.68Price / CashN/A24.8225.6618.27Price / BookN/A7.7111.764.58Net Income$112.87M$242.04M$3.27B$997.71M7 Day Performance-0.94%0.15%1.13%0.77%1 Month Performance9.60%5.53%8.30%6.95%1 Year Performance-70.66%9.53%62.26%11.66% PACS Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PACSPACS Group2.859 of 5 stars$11.64+0.3%$33.33+186.4%-70.7%$1.77B$3.11B0.0032,433RDNTRadNet3.1727 of 5 stars$69.59-0.7%$71.60+2.9%+8.3%$5.39B$1.83B-347.9311,021Positive NewsInsider TradeSHCSotera Health2.2091 of 5 stars$16.39-0.2%$16.00-2.4%+6.0%$4.67B$1.10B204.903,000News CoveragePositive NewsOPCHOption Care Health4.5258 of 5 stars$28.06-2.4%$35.75+27.4%-10.4%$4.66B$5.37B22.458,088News CoveragePositive NewsBTSGBrightSpring Health Services2.2229 of 5 stars$24.08-3.2%$25.67+6.6%+88.8%$4.41B$11.27B77.6835,000Positive NewsNAKAKindlyMDN/A$9.17-9.5%N/AN/A$3.81B$2.72M-10.66N/AGap DownWGSGeneDx2.3911 of 5 stars$121.87-5.3%$101.63-16.6%+305.4%$3.70B$305.45M2,437.401,200CONConcentra Group Holdings Parent2.2088 of 5 stars$23.36-1.2%$27.50+17.7%-2.8%$3.03B$1.90B19.6311,250News CoveragePositive NewsSGRYSurgery Partners2.9216 of 5 stars$23.04-2.5%$33.00+43.2%-29.0%$3.03B$3.11B-16.1115,000Positive NewsPRVAPrivia Health Group3.7872 of 5 stars$21.40-2.7%$28.00+30.8%+14.4%$2.70B$1.74B194.561,140Analyst ForecastAnalyst RevisionGap UpVCYTVeracyte2.6639 of 5 stars$29.55-4.7%$40.90+38.4%-3.8%$2.44B$445.76M89.55790News Coverage Related Companies and Tools Related Companies RDNT Alternatives SHC Alternatives OPCH Alternatives BTSG Alternatives NAKA Alternatives WGS Alternatives CON Alternatives SGRY Alternatives PRVA Alternatives VCYT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:PACS) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersNew Banking Law #1582 Could Unlock $21 Trillion for AmericansDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PACS Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PACS Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PACS Stock Alerts